Quasar Medical Opens New Thailand Manufacturing Facility to Expand MedTech Production Capacity

Key Takeaways

• Quasar Medical opened a new manufacturing facility in Chonburi, Thailand on April 24, 2026
• The facility increases global manufacturing capacity for interventional and minimally invasive medical devices
• Expansion strengthens regional supply chain capabilities for MedTech customers across Asia-Pacific

---

CHONBURI, Thailand - Quasar Medical, a global leader in interventional and minimally invasive medical device manufacturing, officially opened its new production facility in Chonburi, Thailand on April 24, 2026. The expansion marks a significant milestone in the company’s international growth strategy and regional market presence.

Strategic Manufacturing Expansion

The new Chonburi facility represents Quasar Medical’s commitment to meeting growing demand for advanced medical technologies in the Asia-Pacific region. The manufacturing plant will focus on producing interventional and minimally invasive medical devices for leading MedTech customers worldwide.

“This facility positions us to better serve our customers across Asia while maintaining the highest quality standards,” the company stated in its announcement. The Thailand location provides strategic advantages including proximity to key markets, skilled workforce availability, and favorable manufacturing conditions.

Market Impact and Supply Chain Benefits

The facility expansion addresses increasing global demand for medical devices, particularly in interventional cardiology and minimally invasive surgical procedures. By establishing regional manufacturing capabilities, Quasar Medical can reduce supply chain complexities and delivery times for customers throughout Asia-Pacific.

The Thailand facility joins Quasar Medical’s existing global manufacturing network, enhancing the company’s ability to scale production and respond to market needs. This geographic diversification also provides supply chain resilience and risk mitigation benefits.

Industry Growth Alignment

The timing aligns with robust growth in the Asia-Pacific medical device market, driven by aging populations, increasing healthcare access, and rising demand for advanced medical technologies. Thailand’s established medical device manufacturing ecosystem and government support for healthcare industry development make it an attractive location for medical technology companies.

Quasar Medical’s investment demonstrates confidence in the region’s long-term growth potential and the company’s commitment to supporting healthcare advancement through innovative medical device manufacturing.

---

Frequently Asked Questions

What types of medical devices will be manufactured at the Thailand facility?

The facility will produce interventional and minimally invasive medical devices, focusing on products for leading MedTech customers globally.

How does this expansion benefit patients in Asia-Pacific?

The regional manufacturing facility can reduce supply chain delays and improve access to advanced medical devices across Asia-Pacific markets.

When will the facility begin full production operations?

While the facility officially opened on April 24, 2026, specific production timelines and capacity details have not been disclosed by Quasar Medical.